Literature DB >> 28800925

Resveratrol increases phagocytosis and lipopolysaccharide-induced interleukin-1β production, but decreases surface expression of Toll-like receptor 2 in THP-1 monocytes.

Susan J Zunino1, Daniel H Hwang2, Shurong Huang3, David H Storms4.   

Abstract

THP-1 monocytes were used to evaluate the effects of physiological levels of resveratrol aglycone, resveratrol-3-O-glucuronide, resveratrol-4'-O-glucuronide, and resveratrol-3-O-sulfate on phagocytosis, IL-1β, IL-1α, and IL-18 production, viability, and TLR2 and TLR4 expression. THP-1 cells were treated with 1, 5, 10, and 15μM resveratrol or metabolites. Resveratrol-3-O-glucuronide, resveratrol-4'-O-glucuronide, and resveratrol-3-O-sulfate had no effect on the functional parameters tested. Resveratrol aglycone increased phagocytosis at concentrations of 5, 10, and 15μM and LPS-induced IL-1β production at concentrations of 10 and 15μM. Expression of TLR4 increased slightly after resveratrol treatment, but surface expression of TLR2 was reduced as resveratrol concentrations increased. Our data suggest that resveratrol may be effective in modulating monocyte function in an environment where there is direct exposure to the aglycone, such as at the gut epithelium. Published by Elsevier Ltd.

Entities:  

Keywords:  IL-1β; Monocytes; Phagocytosis; Resveratrol; Toll-like receptors

Mesh:

Substances:

Year:  2017        PMID: 28800925     DOI: 10.1016/j.cyto.2017.07.023

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  2 in total

Review 1.  Progress of Research into Novel Drugs and Potential Drug Targets against Porcine Pseudorabies Virus.

Authors:  Mo Zhou; Muhammad Abid; Shinuo Cao; Shanyuan Zhu
Journal:  Viruses       Date:  2022-08-11       Impact factor: 5.818

Review 2.  The impact of resveratrol on skin wound healing, scarring, and aging.

Authors:  Andrzej Hecker; Marlies Schellnegger; Elisabeth Hofmann; Hanna Luze; Sebastian Philipp Nischwitz; Lars-Peter Kamolz; Petra Kotzbeck
Journal:  Int Wound J       Date:  2021-05-05       Impact factor: 3.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.